OVID
Ovid Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
OVID fundamentals
Ovid Therapeutics (OVID) released its earnings on Aug 13, 2025: revenue was 6.30M (YoY +3627.81%), beat estimates; EPS was -0.06 (YoY -150.00%), beat estimates.
Revenue / YoY
6.30M
+3627.81%
EPS / YoY
-0.06
-150.00%
Report date
Aug 13, 2025
Earnings Call
7:00 AM on Aug 13, 2025
Meeting link.EPS
Revenue
Revenue & Expenses
OVID has released its 2025 Q3 earnings report, with revenue of 132.00K, reflecting a YoY change of -23.70%, and net profit of -12.16M, showing a YoY change of 13.19%. The Sankey diagram below clearly presents OVID's revenue sources and cost distribution.
Key Indicators
Ovid Therapeutics (OVID) key financial stats and ratios, covering profitability, financial health, and leverage.
Ovid Therapeutics (OVID)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Ovid Therapeutics (OVID)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Ovid Therapeutics (OVID)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Ovid Therapeutics (OVID) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Ovid Therapeutics (OVID) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is Ovid Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Ovid Therapeutics’s earnings call?What is the revenue and EPS growth rate for Ovid Therapeutics year over year?What factors drove the changes in Ovid Therapeutics's revenue and profit?What is Ovid Therapeutics's gross profit margin?What is the market's earnings forecast for Ovid Therapeutics next quarter?What does Ovid Therapeutics do and what are its main business segments?Did Ovid Therapeutics beat or miss consensus estimates last quarter?
